WuXi XDC and LigaChem Biosciences expands MoU to accelerate ADC development
WuXi XDC's fully integrated ADC discovery service platform will significantly boost the speed and efficiency of LigaChem's ADC development programs
WuXi XDC's fully integrated ADC discovery service platform will significantly boost the speed and efficiency of LigaChem's ADC development programs
MET-X, a novel metallo-beta-lactamase (MBL) inhibitor, has shown best-in-class performance in preclinical studies
Eleven CRDMOs collaborate to form IPSO with the aim to elevate India’s position in the global pharmaceutical value-chain
The Formulation & Technology Centre intends to function as a technology storefront, offering advanced formulation and processing solutions to address the growing demand for complex drug formulations
Innovative chronic pain treatment receives IP protection in India's $55 billion pharmaceutical market
Evrysdi is the only non-invasive disease-modifying SMA treatment and is approved in over 100 countries
The company will offer end-to-end services and solutions for the sector with a specific focus on sustainability
Plans underway to expand screening capacity by 50% for greater accessibility
Subscribe To Our Newsletter & Stay Updated